INSIDER
Congresswomen press FDA on why a proposal to ban hair-straightening chemicals is delayed
Read full article: Congresswomen press FDA on why a proposal to ban hair-straightening chemicals is delayedTwo U.S. House members who first pushed the Food and Drug Administration in 2023 to investigate the health risks of hair straighteners used primarily by Black women are asking the agency why it has twice delayed its target date to propose a ban on products containing formaldehyde.
After baby's death, Kentucky parents sue infant formula maker at center of 2022 crisis
Read full article: After baby's death, Kentucky parents sue infant formula maker at center of 2022 crisisThe parents of Kentucky baby who died last fall after drinking bacteria-tainted infant formula are the latest to sue manufacturer Abbott Nutrition.
Tornado damage to Pfizer plant unlikely to cause major drug supply shortages, FDA says
Read full article: Tornado damage to Pfizer plant unlikely to cause major drug supply shortages, FDA saysA tornado that tore through eastern North Carolina and struck a large Pfizer pharmaceutical plant has damaged its drug storage facility but not its medicine production areas.
Panel calls for stronger leadership of FDA foods program
Read full article: Panel calls for stronger leadership of FDA foods programA panel is calling for changes at the federal agency that oversees most of the nation's food supply, saying revamped leadership, a clear mission and more urgency are needed to prevent illness outbreaks and to promote good health.
FDA concedes delays in response to baby formula shortage
Read full article: FDA concedes delays in response to baby formula shortageU.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.
FDA chief says long-awaited opioid review still in the works
Read full article: FDA chief says long-awaited opioid review still in the worksThe head of the Food and Drug Administration says a government review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway.
FDA chief's long-promised opioid review faces skepticism
Read full article: FDA chief's long-promised opioid review faces skepticismThe head of the Food and Drug Administration says a comprehensive review of the opioid painkillers that triggered the nation's ongoing overdose epidemic is in the works.
FDA chief struggles to explain slow response on baby formula
Read full article: FDA chief struggles to explain slow response on baby formulaThe head of the Food and Drug Administration testified about a series of setbacks that led to a months-long delay in inspecting the plant at the center of a nationwide baby formula shortage.
Senate confirms Biden's FDA pick despite political divisions
Read full article: Senate confirms Biden's FDA pick despite political divisionsThe Senate has narrowly confirmed President Joe Biden’s pick to lead the Food and Drug Administration, filling a position that had been open for more than a year.